Celgene: Biocon enters into a settlement agreement with Celgene Corp; stock trades flat
The pharma company has settled the suit through a confidential settlement agreement with Celgene Corporation relating to patents for generic Revlimid drug
Read full article »
CEO
Celgene develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.
Read more